SCHEMBL21055271

SCHEMBL21055271

Cc1ccc(S(=O)(=O)O[C@H]2CC[C@H](Oc3cccn(C)c3=O)CC2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.51
CYP1A2 P05177 1/20 0.41
VDR P11473 1/20 0.39
GPR6 P46095 3/20 0.39
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
HTR6 P50406 1/20 0.37
CYP2C9 P11712 1/20 0.36
CYP3A4 P08684 1/20 0.35
CYP2C19 P33261 1/20 0.35
MERTK Q12866 1/20 0.35
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
HPGD P15428 1/20 0.35
SCD O00767 2/20 0.35
ESR1 P03372 1/20 0.34
GAA P10253 1/20 0.34
ESR2 Q92731 1/20 0.34
LMNA P02545 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21055269 1.00 CYP2D6 (0.51) CYP2D6CYP1A2VDRGPR6MEN1
SCHEMBL21055393 0.78 CYP2D6 (0.49) CYP2D6CYP1A2VDRGPR6MEN1
SCHEMBL21055396 0.78 CYP2D6 (0.49) CYP2D6CYP1A2VDRGPR6MEN1
SCHEMBL10376015 0.77 CYP2D6 (0.67) CYP2D6CYP1A2VDRKMT2AHTR6
SCHEMBL657896 0.77 CYP2D6 (0.67) CYP2D6CYP1A2VDRKMT2AHTR6
SCHEMBL24247003 0.75 SCD (0.42) GPR6KMT2AMERTKSCDBRD4
SCHEMBL21055558 0.74 CYP2D6 (0.53) CYP2D6CYP1A2VDRMEN1KMT2A
SCHEMBL21055560 0.74 CYP2D6 (0.53) CYP2D6CYP1A2VDRMEN1KMT2A
SCHEMBL21055454 0.73 CYP2D6 (0.52) CYP2D6CYP1A2MEN1KMT2ACYP2C9
SCHEMBL21055453 0.73 CYP2D6 (0.52) CYP2D6CYP1A2MEN1KMT2ACYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11247990-B1 Bicyclic fused pyridine compounds as inhibitors of TAM kinases ARRAY BIOPHARMA INC (US) 2022-02-15 US disclosed
WO-2019113190-A1 BICYCLIC FUSED PYRIDINE COMPOUNDS AS INHIBITORS OF TAM KINASES ARRAY BIOPHARMA INC. (US) 2019-06-13 WO disclosed
US-9349964-B2 Organic light emitting diode and manufacturing method thereof LG CHEM, LTD. (KR) 2016-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11247990-B1 Bicyclic fused pyridine compounds as inhibitors of TAM kinases MAP3K1, MAP3K3, MAP3K2 CYP2D6 3215/4885CYP1A2 2249/4885VDR 1879/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.